De Gecompliceerde Kliniek 2004:
Als protocollen en richtlijnen tekortschieten. Samenstelling en redactie: A. Bakker en A. Korzec, 2003.

De Gecompliceerde Kliniek 2003:
Als protocollen en richtlijnen tekortschieten. Samenstelling en redactie: A. Bakker en A. Korzec, 2002.

Bakker A, van Balkom AJLM, Spinhoven Ph (2002) SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatrica Scandinavica; 106: 163-167.

Bakker A, Spinhoven Ph, van Balkom AJLM, van Dyck R (2002). Relevance of assessment of cognitions during panic attacks in the treatment of panic disorder. Psychotherapy and Psychosomatics; 71: 158-161.

Bakker A, Spinhoven Ph, van der Does AJ, van Balkom AJLM, van Dyck R (2002). Locus of control orientation in panic disorder and the differential effects of treatment. Psychotherapy and Psychosomatics; 71: 85-89.

Couvee JE, Bakker A, Zitman FG (2002). The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users. Psychotherapy and Psychosomatics; 71: 263-268.

Vergouwen ACM, Bakker A (2002), Patient adherence with antidepressant treatment. British Journal of Psychiatry; 181: 78-79.

Bakker A, van Balkom AJLM, van Dyck R (2001) Comparing psychotherapy and pharmacotherapy. American Journal of Psychiatry; 158: 1164-1166.

Bakker A, van Balkom AJLM, van Dyck R (2000) Selective Serotonin Reuptake Inhibitors in the treatment of panic disorder and agoraphobia. International Clinical Psychopharmacology; 15 (Suppl. 2): S25-S30.

Bakker A, Spinhoven Ph, van Balkom AJLM, Vleugel L, van Dyck R (2000). Cognitive therapy by allocation versus cognitive therapy by preference in the treatment of panic disorder. Psychotherapy and Psychosomatics; 69: 240-243.

van Balkom AJLM, Spinhoven P, Bakker A, Rammeloo KC, Graatsma AT, Adriaanse MT, van Dyck R (2000). Panic-free status is not associated with improvement on continuous measures in panic disorder. Journal of Nervous and Mental Disease; 188: 840-842.

Bakker A, van Dyck R, Spinhoven Ph, van Balkom AJLM (1999). Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. Journal of Clinical Psychiatry: 60: 831-838.

Bakker A, Spinhoven Ph, van Balkom AJLM, Matser D, van Dyck R (1999). Double-blindness procedure did not mask giving of medication in panic disorder. Journal of Affective Disorders; 54: 189-192.

Bakker A, van Balkom AJLM, Spinhoven P, Blaauw BMJW, van Dyck R (1998). Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review. Journal of Nervous and Mental Disease; 186: 414-419.

Veltman DJ, van Zijderveld GA , van Dyck R, Bakker A (1998). Predictability, controllability, and fear of symp�toms of anxiety in epinephrine-induced panic. Biological Psychiatry; 44: 1017-1026.

van Balkom AJLM, Bakker A, Spinhoven P, Blaauw BMJW, Smeenk S, Ruesink B (1997). A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. Journal of Nervous and Mental Disease; 185: 510-516.

Lecrubier Y, Bakker A, Dunbar G, Judge R, and the Collaborative Paroxetine Panic Study Investigators (1997). A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica; 95: 145-152.

van Balkom AJLM, Nauta MCE, Bakker A (1995). Meta-analysis on the treatment of panic disorder with agoraphobia: review and re-examination. Clinical Psychology and Psychotherapy; 2: 1-14.

Polderman KH, Gooren LJG, Asscheman H, Bakker A, Heine RJ (1994). Induction of insulin resistance by androgens and estrogens. Journal of Clinical Endocrinology and Metabolism; 79: 265-271.

Bakker A, van Kesteren PJM, Gooren LJG, Bezemer PD (1993). The prevalence of transsexualism in the Netherlands. Acta Psychiatrica Scandinavica; 87: 237-238.